Title : Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective study.

Pub. Date : 2021 Nov 2

PMID : 34728668






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OS was significantly poorer in patients with HER2-ABC with a shorter duration of 1LCT, including PB therapy, while subsequent eribulin therapy improved OS. pladienolide B erb-b2 receptor tyrosine kinase 2 Homo sapiens